Viking Therapeutics, Inc. Ratios

Ratios Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Efficiency
Assets Average 9.24M14.99M18.33M162.22M293.28M270.38M233.58M189.60M268.51M638.41M
Equity Average -6.70M8.38M10.75M155.61M287.43M260.73M223.11M173.60M246.87M614.35M
Invested Capital -22.13M11.22M10.00M15.38M297.75M277.12M244.34M201.88M145.32M348.42M880.28M
Leverage & Solvency
Equity Ratio -7.270.570.550.610.980.970.950.960.860.950.97
Valuation
Enterprise Value -0.76M18.90M10.85M95.13M-30.51M37.86M-54.69M157.78M565.39M1,499.46M3,581.59M
Market Capitalization 33.00M24.00M115.71M546.67M579.55M410.72M359.88M720.87M1,861.54M4,484.20M
Return Ratios
Return on Capital Employed -1.65%-1.63%-1.97%-0.17%-0.11%-0.17%-0.25%-0.42%-0.40%-0.25%
Return on Assets -1.31%-0.93%-1.04%-0.14%-0.09%-0.15%-0.24%-0.36%-0.32%-0.17%
Return on Equity 1.80%-1.65%-1.77%-0.15%-0.09%-0.15%-0.25%-0.40%-0.35%-0.18%